Page last updated: 2024-10-26

disulfiram and Hypertension, Pulmonary

disulfiram has been researched along with Hypertension, Pulmonary in 1 studies

Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.

Research Excerpts

ExcerptRelevanceReference
"To investigate whether disulfiram alleviates the progression of pulmonary hypertension, rodents were exposed to chronic hypoxia (10% oxygen, 4 weeks) to induce PH."8.12Disulfiram attenuates hypoxia-induced pulmonary hypertension by inhibiting GSDMD cleavage and pyroptosis in HPASMCs. ( Hu, S; Li, F; Wang, L; Wang, T; Xu, Y, 2022)
"To investigate whether disulfiram alleviates the progression of pulmonary hypertension, rodents were exposed to chronic hypoxia (10% oxygen, 4 weeks) to induce PH."4.12Disulfiram attenuates hypoxia-induced pulmonary hypertension by inhibiting GSDMD cleavage and pyroptosis in HPASMCs. ( Hu, S; Li, F; Wang, L; Wang, T; Xu, Y, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hu, S2
Wang, L2
Xu, Y2
Li, F2
Wang, T2

Other Studies

1 other study available for disulfiram and Hypertension, Pulmonary

ArticleYear
Disulfiram attenuates hypoxia-induced pulmonary hypertension by inhibiting GSDMD cleavage and pyroptosis in HPASMCs.
    Respiratory research, 2022, Dec-16, Volume: 23, Issue:1

    Topics: Animals; Disulfiram; Hypertension, Pulmonary; Hypoxia; Inflammasomes; Interleukin-18; Intracellular

2022
Disulfiram attenuates hypoxia-induced pulmonary hypertension by inhibiting GSDMD cleavage and pyroptosis in HPASMCs.
    Respiratory research, 2022, Dec-16, Volume: 23, Issue:1

    Topics: Animals; Disulfiram; Hypertension, Pulmonary; Hypoxia; Inflammasomes; Interleukin-18; Intracellular

2022
Disulfiram attenuates hypoxia-induced pulmonary hypertension by inhibiting GSDMD cleavage and pyroptosis in HPASMCs.
    Respiratory research, 2022, Dec-16, Volume: 23, Issue:1

    Topics: Animals; Disulfiram; Hypertension, Pulmonary; Hypoxia; Inflammasomes; Interleukin-18; Intracellular

2022
Disulfiram attenuates hypoxia-induced pulmonary hypertension by inhibiting GSDMD cleavage and pyroptosis in HPASMCs.
    Respiratory research, 2022, Dec-16, Volume: 23, Issue:1

    Topics: Animals; Disulfiram; Hypertension, Pulmonary; Hypoxia; Inflammasomes; Interleukin-18; Intracellular

2022